The hazards of pathological neonatal jaundice

Pathological neonatal jaundice is a condition that requires prompt attention and treatment. It may be caused by a variety of factors, including genetics, environment, physical dysfunction and even underlying pathological diseases, posing a threat to the health of newborns. During the treatment process, specific treatment methods should be taken according to the exact cause to ensure the health of the newborn.

1. Genetic factors: Certain genetic diseases may cause neonatal jaundice, such as glucose-6-phosphate dehydrogenase deficiency and abnormal red blood cell membrane structure. These diseases affect the lifespan and function of red blood cells and lead to excessive bilirubin production. Families with a family history of genetic diseases should pay close attention to the health of their babies after birth and conduct genetic testing if necessary.

2. Environmental factors: If the mother takes drugs or comes into contact with toxic substances during the delivery process, it may also affect liver function and induce jaundice. After delivery, the newborn should avoid contact with any potentially harmful substances and need to be raised in a good environment.

3. Physiological and disease factors: The physiological functions of some newborns have not yet fully developed. For example, the liver is not fully mature, which may affect bilirubin metabolism. Pathological factors such as infection and sepsis can also cause pathological jaundice. In these cases, professional medical examinations are needed to determine the specific problem and use appropriate drugs or blood transfusions. In terms of drugs, phototherapy can be used to promote the decomposition and elimination of bilirubin; sometimes albumin infusion and exchange transfusion therapy may also be required.

Pathological neonatal jaundice may be caused by a variety of factors and has serious health effects on infants, requiring timely detection and treatment. Parents should conduct systematic examinations and treatments under the guidance of professional physicians to prevent possible long-term damage. Independent treatment measures routinely include phototherapy, drug therapy, and exchange transfusion therapy in serious cases, which must be performed under the advice of medical staff. Timely identification and treatment can help reduce risks and ensure that newborns get the best start in life.